Patent ID: 6858228

Claim:
A compressed solid oral dosage form comprising: a) an active agent containing an effective amount of valsartan or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable additive wherein the active agent is present in an amount of more than 35% by weight based on the total weight of the compressed solid oral dosage form, said solid oral dosage form comprising: valsartan in an amount of about 80 mg hydrochlorothiazide in an amount of about 12.5 mg colloidal anhydrous silica AEROSIL in an amount of about 1.5 mg microcrystalline cellulose AVICEL in an amount of about 31.5 mg polyvinylpyrrolidone CROSPOVI- in an amount of about 20.0 mg DONE magnesium stearate in an amount of about 4.5 mg.